ArticleFrontiers in microbiology2026
Integrating tongue coating microbiome, tongue coating metabolomics, and exhaled breath metabolomics via machine learning to identify chronic atrophic gastritis.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic atrophic gastritis (CAG) is a precancerous gastric condition with limited non-invasive diagnostic options. Alterations in the oral microbiome and its localized metabolic profiles may provide early multi-omics signatures of disease progression. Methods: We performed 16S rRNA gene sequencing of tongue coating samples, along with untargeted metabolomics of both tongue coating and exhaled breath condensate (EBC) in 139 patients, including 99 patients with CAG and 40 with chronic non-atrophic gastritis (CNAG) serving as a disease comparison group. The tongue coating microbiome, tongue coating metabolome, and systemic breath volatile profiles were comprehensively characterized. The clinical cohort was randomly partitioned into a training set and an independent validation test set in a 7:3 ratio. Unsupervised PCA algorithm was implemented for metabolic clustering, and LASSO regression was applied for cross-domain feature integration. Results: CAG patients exhibited significant tongue coating microbiome dysbiosis, characterized by the enrichment of g__Arthrobacter, Veillonella, and Streptococcus, and depletion of Prevotella and Haemophilus compared to the CNAG disease comparison group. Metabolomic profiling of the tongue coating uncovered pronounced metabolic alterations, mapped via unsupervised PCA scores (PC1: 49.5%; PC2: 5.7%), identifying 56 differential tongue coating metabolites that were predominantly upregulated and significantly enriched in alanine, aspartate, and glutamate metabolism pathways. Concurrently, EBC metabolomics mapped via PCA coordinate configurations (PC1: 18.8%; PC2: 8.2%) detected 73 differential metabolites based on unadjusted Student's Conclusion: This study establishes an advanced, regularized linear machine learning framework, demonstrating that a streamlined 26-feature panel of tongue coating and exhale profiles offers a transparent, non-invasive triage tool for chronic atrophic gastritis. These tightly synchronized local and systemic multi-source trajectories provide crucial insights into oral-gastric microbial interactions and host-microbiome co-metabolism in CAG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.